Crossmark

Ten years of iron chelation in a patient with superficial siderosis

Crossref DOI link: https://doi.org/10.1007/s10072-019-03791-w

Published Online: 2019-03-04

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Levy, Michael https://orcid.org/0000-0002-7969-8346
Funding

Funding for this research was provided by:

Apopharma
License Information

Text and Data Mining valid from 2019-03-04
More Information

Article History

Received: 15 February 2019

Accepted: 25 February 2019

First Online: 4 March 2019

Compliance with ethical standards

:

: The patient provided informed consent to publish the details of his case.

: Dr. Levy previously received a research award from the manufacturer of Ferriprox (deferiprone), Apopharma Inc., to conduct a trial of deferiprone in superficial siderosis between 2014 and 2016.